Clinical Trial Update: Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates adebrelimab with nab-paclitaxel, oxaliplatin and tegafur (AOS) as perioperative therapy for locally advanced resectable gastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Nab-paclitaxel (paclitaxel protein-bound)
• OXALIPLATIN (Oxaliplatin)
• tegafur (tegafur)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma | Phase 2 | Status: RECRUITING